NCT06825702Phase 2Recruiting

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

Study sponsor: Kiora Pharmaceuticals, Inc. · KPRX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-11Estimated

Enrollment · participants28Estimated

Source updated2026-09-09Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.